Flexing their muscle
Before Medtronic imploded the company was ruthless when it came to IP. Hence the reason we are not surprised that Insulet now the market leader is doing the same thing. As everyone knows there are lots of Omnipod wannabes yep everyone wants a patch pump. Hence the reason this caught our eye:
According to the Juve Patent site-
“Italian company Menarini Diagnostics may no longer sell its insulin pump GlucoMen Day Pump through Berlin Chemie, which is its subsidiary in Germany. Insulet recently enforced an injunction handed down by Düsseldorf Regional Court.”
Now this in no way means this . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.